You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership - whether it lies with the state, parents, or the individual as they mature - further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project? (Answer in 250 words)
Aryan Yadav, AIR 31, 2025
This case involves issues of bio-ethics & new technology like gene sequencing.
a) Ethical Issues 1. Violation of principle of prior informed consent as parents not aware of risks 2. Potential violation of non-maleficence (no harm) Principle by private companies 3. Deontological ethics -> Treating of humans as means to an end hence unethical 4. Utilitarian argument -> Net result is good 5. Lack of data privacy => exploitation of data by private sector 6. Insufficient regulatory framework 7. Violation of justice => selection of babies 8. Duty to protect rights of citizens 9. Conflict of intrests => public good v/s profit
b) Stakeholders
Conflicting intrests 1. Parents wont to protect health of babies 2. Babies when old wont rights over their data 3. Pharma companies wont to maximize profits 4. I have to balance various conflicting intrests & ensure public welfare 5. Government wonts to protect rights of citizens but also promote R&D, innovation in health sector
c) Guiding Ethical Principles 1. Beneficence -> Goal should be health improvement 2. Non-maleficance => Avoid any harm to patients 3. Prior informed consent => parents must be made aware of all risks 4. Data privacy => ensure no misuse 5. Data autonomy => can withdraw consent later if needed 6. Distributive justice => Ensure benefits of research shared equitably 7. No harm principle (JS Mill) => Minimize harm
Hence following these principles balances individual rights & collective welfare, avoiding science w/o humanity (Gandhian sin).